Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trial

202411 citationsJournal Articlegold Open Access

Authors

gov ; Unique identifier: NCT01131676.

Good health and well-being

Published in: Cardiovascular Diabetology

Volume 23, Issue 1, pp. 248-248

Field-Weighted Citation Impact: 4.01